Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > MD Anderson trial post?

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on Mar 31, 2021 1:34pm

101 Views

Post# 32915249

RE:RE:MD Anderson trial post?

Yes, but if you search MD Anderson, it's nowhere to be found as of today. I believe someone posted it before, so it's disappeared from their clinical trials database you can search.

MHemorrhage wrote: I assume all is still same, recall THTX March 24 news release:

Funda Meric-Bernstam, M.D., Chair of the Department of Investigational Cancer Therapeutics at The University of Texas MD Anderson Cancer Center is the Lead Principal Investigator of the Phase 1 trial for TH1902.

Wino115 wrote: I believe JFM or Qwerty were able to find the trial up on the MD Anderson trial website and posted the link. I couldn't find that old Stockhouse post. The lead investigator is Funda Meric-Bernstam; however, I was not able to find it anywhere on the MD Anderson site? Do you think THTX moved it over to someone else or a different facility? Perhaps something happened there. The clinicaltrials website still lists her as lead investigator but it hasn't been updated since January. Bit of a mystery.